Skip to main content
Log in

Amiodarone pulmonary toxicity

  • Editorials
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Heger JJ, Prystowsky EN, Jackman WM, Naccarelli GV, Warfel KA, Rinkenberger RL, Zipes DP (1981) Amiodarone: clinical efficacy and electrophysiology during long term therapy for recurrent ventricular tachycardia and ventricular fibrillation. N Engl J Med 305:539–545

    PubMed  Google Scholar 

  2. Canada AT, Lesko LJ, Haffajee CI, Johnson B, Asdouian GK (1983) Amiodarone for tachyarrhythmias: pharmacology, kinetics, and efficacy. Drug Intell Clin Pharm 17:100–104

    PubMed  Google Scholar 

  3. Martin WJ II, Kachel DL, Vilen T, Natarajan V (1989) Mechanism of phospholipidosis in amiodarone pulmonary toxicity. J Pharmacol Exp Ther 251:272–278

    PubMed  Google Scholar 

  4. Martin WJ II, Rosenow EC III (1988) Amiodarone pulmonary toxicity: I. Recognition and pathogenesis. Chest 93:1067–1075

    Google Scholar 

  5. Adams PC, Holt DW, Storey GCA, Morley AR, Callaghan J, Campbell WF (1985) Amiodarone and its desethyl metabolite; tissue distribution and morphologic changes during long-term therapy. Circulation 72:1064–1075

    PubMed  Google Scholar 

  6. Wood DL, Osborn MJ, Rook J, Holmes DR (1985) Amiodarone pulmonary toxicity report of two cases associated with rapidly progressive fatal adult respiratory distress syndrome after pulmonary angiography. Mayo Clin Proc 60:601–603

    PubMed  Google Scholar 

  7. Nalos PC, Kass RM, Gang ES, Fishbein MC, Mandel WJ, Peter T (1987) Life-threatening postoperative pulmonary complications in patients with previous amiodarone pulmonary toxicity undergoing cardiothoracic operations. J Thorac Cardiovasc Surg 93:904–912

    PubMed  Google Scholar 

  8. Kudenchuk PJ, Pierson DJ, Greene HL, Graham EL, Sears GK, Trobaugh GB (1984) Perspective evaluation of amiodarone pulmonary toxicity. Chest 86:541–548

    PubMed  Google Scholar 

  9. Martin WJ II (1990) Mechanisms of amiodarone pulmonary toxicity. Clin Chest Med 11:131–138

    PubMed  Google Scholar 

  10. Camus P, Mendenhale HM (1986) Pulmonary sequestration of amiodarone and desethylamiodarone. J Pharmacol Exp Ther 237:867–873

    PubMed  Google Scholar 

  11. Hostetler KY, Reasor MJ, Walker ER, Yazaki PJ, Frazee BW (1986) Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats. Biochim Biophys Acta 875:400–405

    PubMed  Google Scholar 

  12. Martin WJ II, Standing JE (1988) Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospolipidosis in the bronchoalveolar lavage of human subjects. J Pharmacol Exp Ther 244:774–779

    PubMed  Google Scholar 

  13. Akoun GM, Gauthier-Rahman S, Milleron BJ, Perrot JY, Mayaud CM (1984) Amiodarone-induced hypersensitivity pneumonitis; evidence of an immunological cell-mediated mechanism. Chest 85:133–135

    PubMed  Google Scholar 

  14. Akoun GM, Milleron BJ, Badaro DM, Mayaud CM, Liote HA (1989) Pleural T-lymphocyte subsets in amiodarone-associated plenuropneumonitis. Chest 95:596–597

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported in part by NIH grant HL36124

Rights and permissions

Reprints and permissions

About this article

Cite this article

Retz, J.L., Martin, W.J. Amiodarone pulmonary toxicity. Intensive Care Med 18, 388–390 (1992). https://doi.org/10.1007/BF01694339

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01694339

Navigation